NasdaqGS:TECHLife Sciences
Reassessing Bio-Techne (TECH) Valuation After a Weak Year and Recent Share Price Rebound
Why Bio-Techne Is Back On Investors Radar
Bio-Techne (TECH) has quietly fallen about 18% this year, even as the stock gained roughly 14% over the past 3 months. This has set up an interesting reset in expectations for long term holders.
See our latest analysis for Bio-Techne.
That mix of a weak year to date share price return of about negative 18 percent, together with a solid 90 day share price rebound, suggests sentiment is stabilizing as investors refocus on Bio Techne’s steady revenue and...